BackLotus Bio-Technology Development Overview

Lotus Bio-Technology Development Total Liabilities

Lotus Bio-Technology Development's total liabilities is $120K.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$116771.00
↑ 33.03% YoYΔ $28990.00 vs prior year quarter

Peer trimmed avg / median

Loading

Lotus Bio-Technology Development Total Liabilities History

Loading

Lotus Bio-Technology Development vs. peers: Total Liabilities Comparison

Loading

Lotus Bio-Technology Development Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Lotus Bio-Technology Development (LBTD) FAQ

The latest total liabilities for LBTD is $120K as of December 2017. That compares with $88K in the prior-year period — up 33.0% year over year. Investors often review this figure alongside Lotus Bio-Technology Development's historical trend and sector peers before judging valuation or financial health.

Over the past year, LBTD's total liabilities moved from $88K to $120K — a 33.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lotus Bio-Technology Development's operating scale or balance-sheet position.

A total liabilities figure of $120K for LBTD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LBTD's total liabilities ($120K), review year-over-year change from $88K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.